annual current liabilities:
$344.15M+$63.72M(+22.72%)Summary
- As of today (July 7, 2025), RARE annual total current liabilities is $344.15 million, with the most recent change of +$63.72 million (+22.72%) on December 31, 2024.
- During the last 3 years, RARE annual current liabilities has risen by +$162.78 million (+89.75%).
- RARE annual current liabilities is now at all-time high.
Performance
RARE Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$291.67M-$52.48M(-15.25%)Summary
- As of today (July 7, 2025), RARE quarterly total current liabilities is $291.67 million, with the most recent change of -$52.48 million (-15.25%) on March 31, 2025.
- Over the past year, RARE quarterly current liabilities has increased by +$46.09 million (+18.77%).
- RARE quarterly current liabilities is now -15.25% below its all-time high of $344.15 million, reached on December 31, 2024.
Performance
RARE quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
RARE Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +22.7% | +18.8% |
| 3 y3 years | +89.8% | +74.4% |
| 5 y5 years | +233.2% | +48.2% |
RARE Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +89.8% | -15.3% | +33.7% |
| 5 y | 5-year | at high | +233.2% | -15.3% | +129.6% |
| alltime | all time | at high | >+9999.0% | -15.3% | +9048.9% |
RARE Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $291.67M(-15.3%) |
| Dec 2024 | $344.15M(+22.7%) | $344.15M(+20.8%) |
| Sep 2024 | - | $285.01M(+4.4%) |
| Jun 2024 | - | $272.87M(+11.1%) |
| Mar 2024 | - | $245.57M(-12.4%) |
| Dec 2023 | $280.44M(+7.4%) | $280.44M(+10.4%) |
| Sep 2023 | - | $253.98M(+3.9%) |
| Jun 2023 | - | $244.38M(+12.0%) |
| Mar 2023 | - | $218.18M(-16.5%) |
| Dec 2022 | $261.21M(+44.0%) | $261.21M(+14.9%) |
| Sep 2022 | - | $227.36M(+3.0%) |
| Jun 2022 | - | $220.64M(+31.9%) |
| Mar 2022 | - | $167.23M(-7.8%) |
| Dec 2021 | $181.37M(-4.3%) | $181.37M(+33.4%) |
| Sep 2021 | - | $135.93M(+7.0%) |
| Jun 2021 | - | $127.07M(+0.0%) |
| Mar 2021 | - | $127.04M(-33.0%) |
| Dec 2020 | $189.61M(+83.6%) | $189.61M(-5.8%) |
| Sep 2020 | - | $201.19M(-8.4%) |
| Jun 2020 | - | $219.73M(+11.6%) |
| Mar 2020 | - | $196.86M(+90.6%) |
| Dec 2019 | $103.30M | $103.30M(+14.4%) |
| Sep 2019 | - | $90.31M(+20.4%) |
| Jun 2019 | - | $75.01M(+12.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $66.88M(-10.5%) |
| Dec 2018 | $74.72M(+5.2%) | $74.72M(+12.1%) |
| Sep 2018 | - | $66.68M(+1.0%) |
| Jun 2018 | - | $66.05M(+14.7%) |
| Mar 2018 | - | $57.58M(-18.9%) |
| Dec 2017 | $71.01M(+17.8%) | $71.01M(+10.5%) |
| Sep 2017 | - | $64.26M(+2.5%) |
| Jun 2017 | - | $62.67M(+21.1%) |
| Mar 2017 | - | $51.76M(-14.1%) |
| Dec 2016 | $60.26M(+115.8%) | $60.26M(+19.5%) |
| Sep 2016 | - | $50.43M(+57.7%) |
| Jun 2016 | - | $31.98M(+7.0%) |
| Mar 2016 | - | $29.88M(+7.0%) |
| Dec 2015 | $27.92M(+123.0%) | $27.92M(+12.9%) |
| Sep 2015 | - | $24.73M(+7.3%) |
| Jun 2015 | - | $23.04M(+61.8%) |
| Mar 2015 | - | $14.24M(+13.8%) |
| Dec 2014 | $12.52M(+111.4%) | $12.52M(+13.1%) |
| Sep 2014 | - | $11.07M(+23.8%) |
| Jun 2014 | - | $8.94M(+31.3%) |
| Mar 2014 | - | $6.81M(+15.0%) |
| Dec 2013 | $5.92M(+85.7%) | $5.92M(+5.6%) |
| Sep 2013 | - | $5.61M(+75.9%) |
| Dec 2012 | $3.19M(+219.1%) | $3.19M |
| Dec 2011 | $999.00K | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual total current liabilities?
- What is the all time high annual current liabilities for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual current liabilities year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly current liabilities year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual total current liabilities?
The current annual current liabilities of RARE is $344.15M
What is the all time high annual current liabilities for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual total current liabilities is $344.15M
What is Ultragenyx Pharmaceutical Inc. annual current liabilities year-on-year change?
Over the past year, RARE annual total current liabilities has changed by +$63.72M (+22.72%)
What is Ultragenyx Pharmaceutical Inc. quarterly total current liabilities?
The current quarterly current liabilities of RARE is $291.67M
What is the all time high quarterly current liabilities for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly total current liabilities is $344.15M
What is Ultragenyx Pharmaceutical Inc. quarterly current liabilities year-on-year change?
Over the past year, RARE quarterly total current liabilities has changed by +$46.09M (+18.77%)